Finance

Beta
Lists
OMED:IDX
Jayamas Medica Industri TBK PT
IDR 187.00
-6.50%
(-13.00) 1D
Jun 4, 4:09:00 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OMED...
Open
IDR 202
High
IDR 204
Low
IDR 181
Mkt. cap
5.06T
Avg. vol.
31.41M
Volume
14.04M
Dividend
1.91%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 20, 2024
P/E ratio
12.87
52-wk high
IDR 318
52-wk low
IDR 170
EPS
IDR 15
Shares outstanding
27.06B
No. of employees
1K
Open
IDR 202
High
IDR 204
Low
IDR 181
Mkt. cap
5.06T
Avg. vol.
31.41M
Volume
14.04M
Dividend
1.91%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 20, 2024
P/E ratio
12.87
52-wk high
IDR 318
52-wk low
IDR 170
EPS
IDR 15
Shares outstanding
27.06B
No. of employees
1K
News stories
From sources across the web
About Jayamas Medica Industri TBK PT
CEO-
Employees1.35K
Founded2000
Headquarters-
SectorMedical device
Websiteonemed.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
489.53B
544.05B
593.92B
572.25B
Cost of goods sold
324.83B
360.63B
371.43B
367.36B
Cost of revenue
324.83B
360.63B
371.43B
367.36B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.92B
81.93B
94.61B
92.93B
Operating expense
71.08B
82.90B
98.16B
92.93B
Total operating expenses
395.90B
443.53B
469.59B
460.29B
Operating income
93.63B
100.52B
124.33B
111.96B
Other non operating income
-117.28M
-144.67M
-180.05M
-2.58B
EBT including unusual items
100.13B
125.06B
136.64B
127.20B
EBT excluding unusual items
100.14B
123.21B
138.72B
127.29B
Income tax expense
18.54B
23.97B
23.47B
28.24B
Effective tax rate
18.51%
19.17%
17.18%
22.20%
Other operating expenses
1.18B
942.91M
3.63B
-
Net income
80.97B
100.48B
112.74B
98.37B
Net profit margin
16.54%
18.47%
18.98%
17.19%
Earnings per share
-
-
-
-
Interest and investment income
16.05B
15.64B
16.38B
15.27B
Interest expense
-2.69B
-3.75B
-6.31B
-5.07B
Net interest expenses
13.36B
11.89B
10.07B
10.20B
Depreciation and amortization charges
-
-
-
-
EBITDA
105.68B
114.87B
140.74B
124.88B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer